Results 11 to 20 of about 26,786 (248)

Advances in transcatheter mitral and tricuspid therapies [PDF]

BMC Cardiovascular Disorders, 2020
Background While rheumatic mitral stenosis has been effectively treated percutaneously for more than 20 years, mitral and tricuspid regurgitation treatment appear as a contemporary unmet need.
Pavel Overtchouk, Nicolo Piazza, Juan Granada, Osama Soliman, Bernard Prendergast, Thomas Modine   +5 more
doaj   +4 more sources

Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement: Predictors and Prognosis. [PDF]

, 2021
OBJECTIVES The aims of this study were to document the prevalence of concomitant tricuspid regurgitation (TR) before and after transcatheter aortic valve replacement (TAVR), to quantify potential eligibility for transcatheter tricuspid valve ...
Heg, Dik, Lanz, Jonas, Windecker, Stephan, Tomii, Daijiro, Praz, Fabien, Reineke, David, Pilgrim, Thomas, Okuno, Taishi, Stortecky, Stefan, Wild, Mirjam Gauri   +9 more
core   +1 more source

Transcatheter mitral valve intervention

British Journal of Cardiology, 2021
Mitral regurgitation is a common valvular heart disorder increasing with age. Many patients are ineligible for mitral valve surgery due to their age and other comorbidities. Left untreated, patients develop severe disease with a poor prognosis. The development of lower risk percutaneous mitral valve interventions has helped meet the needs of this ...
Rea, Ganatra, Robert, Smith
openaire   +3 more sources

Transcatheter heart valve interventions for patients with rheumatic heart disease

Frontiers in Cardiovascular Medicine, 2023
Rheumatic heart disease [RHD] is the most prevalent cause of valvular heart disease in the world, outstripping degenerative aortic stenosis numbers fourfold.
Hellmuth Weich, Philip Herbst, Francis Smit, Anton Doubell   +3 more
doaj   +1 more source

Simulation to Success

JACC: Case Reports, 2020
Three-dimensional imaging and printed heart models have become increasingly valuable in the management of patients with complex congenital heart disease.
Eimear M. McGovern, MB BCh BAO, Justin T. Tretter, MD, Ryan A. Moore, MD, Bryan H. Goldstein, MD   +3 more
doaj   +1 more source

Transcatheter and surgical intervention for secondary mitral regurgitation [PDF]

, 2021
Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects in secondary mitral regurgitation of:.
Sharma, H, Su Khin, KL, Shah, BN, Birkhoelzer, Sarah Maria, Steeds, Richard, Pimenta, Dominic, Liu, S, Su Khin, Kyaw Linn, Liu, Simiao, Ahmad, Mahmood, Tahir, Z, Banerjee, Amitava, Myerson, S, Lall, Kulvinder, Liu, Boyang, Lall, K, Prendergast, B, Birkhoelzer, SM, Ahmad, M, Myerson, Saul, Tahir, Zaheer, Shah, Benoy N, Prendergast, Bernard, Banerjee, A, Sharma, Harish, Steeds, R, Pimenta, D, Liu, B   +27 more
core   +1 more source

Outcomes of manually modified microvascular plugs to pulmonary flow restrictors in various congenital heart lesions

Frontiers in Cardiovascular Medicine, 2023
BackgroundThe development of microvascular plugs (MVPs) has enabled novel transcatheter deliverable endoluminal pulmonary flow restrictors (PFRs) with the potential to treat newborns and infants with life-threatening congenital heart diseases (CHDs) in a
Raymond N. Haddad, Jamie Bentham, Ahmed Adel Hassan, Mahmoud Al Soufi, Osama Jaber, Issam El Rassi, Mohamed Kasem   +6 more
doaj   +1 more source

Transcatheter intervention in a child with scimitar syndrome [PDF]

Cardiovascular Journal of Africa, 2016
Scimitar syndrome is a rare congenital heart disease characterised by anomalous pulmonary venous drainage to the inferior vena cava, aortopulmonary collaterals, hypoplasia of the right lung and intracardiac defects. Surgical correction remains the gold-standard therapy.
Wang, Zhouping, Cai, Xiaoyi
openaire   +2 more sources

Transcatheter Device Therapy and the Integration of Advanced Imaging in Congenital Heart Disease

Children, 2022
Transcatheter device intervention is now offered as first line therapy for many congenital heart defects (CHD) which were traditionally treated with cardiac surgery.
Abhay A. Divekar, Yousef M. Arar, Stephen Clark, Animesh Tandon, Thomas M. Zellers, Surendranath R. Veeram Reddy   +5 more
doaj   +1 more source

Transcatheter interventions for functional mitral regurgitation [PDF]

Annals of Cardiothoracic Surgery, 2018
Mitral regurgitation is considered the most prevalent valve disease in the United States and its incidence is increasing due to the aging population. Surgical mitral valve repair and replacement are effective at reducing regurgitation due to ischemia, but many patients with secondary mitral regurgitation do not undergo surgery because they are too high
William Z, Chancellor, Sarah A, Schubert, Gorav, Ailawadi   +2 more
openaire   +2 more sources